Miami, September 2, 2025 — Leads & Copy — Fortress Biotech, Inc. (Nasdaq: FBIO) announced that Chairman, President, and CEO Lindsay A. Rosenwald, M.D., will present a corporate overview at the H.C. Wainwright 27th Annual Global Investment Conference. The presentation will be available on-demand for conference attendees starting September 5, 2025, at 7:00 a.m. ET. The company will also attend virtual one-on-one meetings during the conference from September 8-11, 2025.
Fortress Biotech is focused on acquiring and advancing assets to enhance long-term value for shareholders. It has eight marketed prescription pharmaceutical products and multiple programs in development across various therapeutic areas, including oncology, dermatology, and rare diseases. The company partners with institutions such as AstraZeneca, City of Hope, and Dana Farber Cancer Center.
Contact: Jaclyn Jaffe, Fortress Biotech, Inc., (781) 652-4500, ir@fortressbiotech.com
Media Contact: Tony Plohoros, 6 Degrees, (908) 591-2839, tplohoros@6degreespr.com
Source: Fortress Biotech, Inc.
